Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review - Top-Institutions - MDSpire

Adverse Events Related to Treatment and Quality of Life Outcomes in Patients with Mucosal Head and Neck Squamous Cell Carcinoma Undergoing Immune Checkpoint Inhibitor Therapy: A Scoping Review

  • By

  • N. D. O'Donnell

  • E. C. Ward

  • L. R. Wishart

  • R. Perera

  • C. Barrett

  • K. A. Edmiston

  • E. Mitchell

  • A. Pigott

  • R. Pitt

  • K. Russell

  • B. A. Chan

  • R. Ladwa

  • June 1, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

  • by N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa

  • June 1, 2026

Related Content

The Rise in Homemade Sunscreen Trends and Future Impacts on Skin Cancer Risk: Systematic Review

The prognostic impact of squamous differentiation in bladder cancer after radical cystectomy: a propensity score-matched comparative analysis of pure urothelial carcinoma, urothelial carcinoma with squamous differentiation, and squamous cell carcinoma

Detection of cancer recurrence from Thai-English electronic medical records using sentence embeddings